These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 23979875)

  • 1. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
    Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
    Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of presenting information about invasive follow-up testing on individuals' noninvasive colorectal cancer screening participation decision: results from a discrete choice experiment.
    Benning TM; Dellaert BG; Severens JL; Dirksen CD
    Value Health; 2014 Jul; 17(5):578-87. PubMed ID: 25128051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of colorectal cancer screening methods in Iran.
    Allameh Z; Davari M; Emami MH
    Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eliciting population preferences for mass colorectal cancer screening organization.
    Nayaradou M; Berchi C; Dejardin O; Launoy G
    Med Decis Making; 2010; 30(2):224-33. PubMed ID: 19692710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Survey of Patient Factors Associated with Colorectal Cancer Screening Preferences.
    Zhu X; Parks PD; Weiser E; Fischer K; Griffin JM; Limburg PJ; Finney Rutten LJ
    Cancer Prev Res (Phila); 2021 May; 14(5):603-614. PubMed ID: 33888515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening.
    de Bekker-Grob EW; Hol L; Donkers B; van Dam L; Habbema JD; van Leerdam ME; Kuipers EJ; Essink-Bot ML; Steyerberg EW
    Value Health; 2010; 13(2):315-23. PubMed ID: 19912597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
    Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
    Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preferences for colorectal cancer screening.
    Leard LE; Savides TJ; Ganiats TG
    J Fam Pract; 1997 Sep; 45(3):211-8. PubMed ID: 9300000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating preferences for colorectal cancer screening in individuals under age 50 using the Analytic Hierarchy Process.
    Hyams T; Golden B; Sammarco J; Sultan S; King-Marshall E; Wang MQ; Curbow B
    BMC Health Serv Res; 2021 Jul; 21(1):754. PubMed ID: 34325701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer screening mode preferences among US veterans.
    Powell AA; Burgess DJ; Vernon SW; Griffin JM; Grill JP; Noorbaloochi S; Partin MR
    Prev Med; 2009 Nov; 49(5):442-8. PubMed ID: 19747502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the knowledge, behavior and health beliefs of individuals over 50 regarding colorectal cancer screening.
    Tastan S; Andsoy II; Iyigun E
    Asian Pac J Cancer Prev; 2013; 14(9):5157-63. PubMed ID: 24175793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.
    Deutekom M; van Rossum LG; van Rijn AF; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
    Scand J Gastroenterol; 2010 Nov; 45(11):1345-9. PubMed ID: 20560814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferences for colorectal cancer screening strategies: a discrete choice experiment.
    Hol L; de Bekker-Grob EW; van Dam L; Donkers B; Kuipers EJ; Habbema JD; Steyerberg EW; van Leerdam ME; Essink-Bot ML
    Br J Cancer; 2010 Mar; 102(6):972-80. PubMed ID: 20197766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring patient preferences for colorectal cancer screening using a choice-format survey.
    Marshall DA; Johnson FR; Phillips KA; Marshall JK; Thabane L; Kulin NA
    Value Health; 2007; 10(5):415-30. PubMed ID: 17888107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.
    Lew JB; St John DJB; Macrae FA; Emery JD; Ee HC; Jenkins MA; He E; Grogan P; Caruana M; Sarfati D; Greuter MJE; Coupé VMH; Canfell K
    Int J Cancer; 2018 Jul; 143(2):269-282. PubMed ID: 29441568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of CT colonography for colorectal cancer screening in military training facilities and potential impact on HEDIS measures.
    Cash BD; Stamps K; McFarland EG; Spiegel AR; Wade SW
    J Am Coll Radiol; 2013 Jan; 10(1):30-6. PubMed ID: 23290671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline.
    Helsingen LM; Vandvik PO; Jodal HC; Agoritsas T; Lytvyn L; Anderson JC; Auer R; Murphy SB; Almadi MA; Corley DA; Quinlan C; Fuchs JM; McKinnon A; Qaseem A; Heen AF; Siemieniuk RAC; Kalager M; Usher-Smith JA; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G
    BMJ; 2019 Oct; 367():l5515. PubMed ID: 31578196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.